Visalytics
Visalytics
approved EB-2 (NIW)

Acting Assistant Professor

Biotechnology · 2025-04-14

Processing Time
57 days
Decision Date
2025-04-14
Location
Washington
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to advance gene and base editing techniques within complex three-dimensional (3D) organoid models to accurately model genetic diseases. This work involves discovering new gene-based therapies, engineering functional tissues, and enhancing capabilities in organ regeneration and transplantation. The endeavor aims to improve the effectiveness and affordability of treating genetic conditions in the U.S.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses urgent healthcare challenges and improves the U.S. ability to treat genetic conditions effectively.

2 Well-positioned to Advance the Endeavor Met

The petitioner's publication record and 102 citations demonstrate the ability to advance research in biotechnology independently.

3 Balance of Interests Met

The benefits of the research, such as enhanced biomedical innovation and improved patient outcomes, justify waiving the job offer requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 8 peer-reviewed journal articles and 8 abstracts, with 102 citations demonstrating scholarly impact. The case successfully met all three Dhanasar prongs by highlighting the national importance of genetic disease modeling and the petitioner's independent research capabilities. Notably, the case was approved without the submission of recommendation letters.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Conference Presentations
Original Contributions

Similar Cases

Research Scientist

Biotechnology · Malaysia

WeGreened EB-2 (NIW) rfe approved
California 216 days 2025-07-17
The petitioner proposes to develop and apply molecular and genome engineering tools, specifically gene-editing technologies, to study and treat human genetic disorders. This work includes managing microbiome-related diseases and enabling precise genetic interventions for patients with rare genetic conditions to advance personalized medicine.
View Case

Postdoctoral Researcher

Biotechnology · South Korea

WeGreened EB-2 (NIW) approved
California 249 days 2025-05-28
The petitioner proposes to develop advanced biological tools for genetic and molecular cell interfacing, specifically focusing on high-precision CRISPR base editors and synthetic protein biomarkers. This work aims to refine viral vector delivery systems to enable targeted, non-invasive gene therapies for complex neurological diseases.
View Case

Others

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 64 days 2025-02-15
The petitioner proposes to develop and implement advanced synthetic biology and genetic engineering techniques to precisely control gene expression and cellular behavior in mammalian cells. Her work aims to enhance therapeutic applications and biotechnological advancements to address critical healthcare challenges, specifically rising cancer rates in the U.S.
View Case

Operations Manager

Biotechnology · India

WeGreened EB-2 (NIW) approved
California 70 days 2023-02-22
The petitioner proposes to continue her research on the application of cutting-edge gene sequencing and gene editing technologies to identify the causes of genetic diseases. Her work focuses on developing effective diagnostics and identifying novel therapeutic targets for rare genetic disorders such as Huntington’s disease, hemophilia, and sickle cell disease.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-14.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 57 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist